Cargando…
Evaluation of estrogen expression of breast cancer using (18)F-FES PET CT-A novel technique
Estrogen receptor (ER) expression in breast cancer is routinely studied on immunohistochemistry (IHC) of tissue obtained from core biopsy or surgical specimen. Sampling error and heterogeneity of tumor may incorrectly label a breast tumor as ER negative, thus denying patient hormonal treatment. Mole...
Autores principales: | Seenu, Vuthaluru, Sharma, Ankit, Kumar, Rakesh, Suhani, Suhani, Prashanth, Arun, Mathur, Sandeep, Parshad, Rajinder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745867/ https://www.ncbi.nlm.nih.gov/pubmed/33354178 http://dx.doi.org/10.4103/wjnm.WJNM_71_19 |
Ejemplares similares
-
Analyzing the Estrogen Receptor Status of Liver Metastases with [(18)F]-FES-PET in Patients with Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2021) -
18F-FES PET/CT Improves the Detection of Intraorbital Metastases in Estrogen-Receptor-Positive Breast Cancer: Two Representative Cases and Review of the Literature
por: Bodapati, Sandhya, et al.
Publicado: (2022) -
Monitoring the Early Response of Fulvestrant Plus Tanshinone IIA Combination Therapy to Estrogen Receptor-Positive Breast Cancer by Longitudinal (18)F-FES PET/CT
por: He, SiMin, et al.
Publicado: (2019) -
Sub-Diaphragmatic Haemangioma Suspected on F-18 Fdg Pet/Ct Confirmed by Rbc Scintigraphy
por: Prashanth, Arun, et al.
Publicado: (2022) -
Head-to-Head Comparison between (18)F-FES PET/CT and (18)F-FDG PET/CT in Oestrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis
por: Piccardo, Arnoldo, et al.
Publicado: (2022)